Stock Track | Consun Pharmaceutical Soars 9% on Strong H1 Earnings, Dividend Boost

Stock Track08-22

Shares of Consun Pharmaceutical Group Limited (1681.HK) surged as much as 9.45% in intraday trading on Tuesday, August 21, 2024, as investors cheered the company's robust financial performance for the first half of the year and its decision to increase its interim dividend.

In a filing with the Hong Kong stock exchange, Consun Pharmaceutical reported a 15% increase in profit attributable to owners, reaching 399.8 million yuan ($56.9 million) for the six months ended June 30, 2024. The company's revenue for the same period grew by 13% year-over-year to 1.27 billion yuan ($181.2 million).

Buoyed by its strong financial results, the pharmaceutical firm announced an interim dividend of HK$0.003 per share, further fueling investor enthusiasm and driving the stock's intraday rally.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189870175?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-22 00:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189870175","market":"hk","top_or_hot":-1,"title":"Stock Track | Consun Pharmaceutical Soars 9% on Strong H1 Earnings, Dividend Boost","media":"Stock Track","content":"<p>Shares of Consun Pharmaceutical Group Limited (1681.HK) surged as much as 9.45% in intraday trading on Tuesday, August 21, 2024, as investors cheered the company's robust financial performance for the first half of the year and its decision to increase its interim dividend.</p>\n\n<p>In a filing with the Hong Kong stock exchange, Consun Pharmaceutical reported a 15% increase in profit attributable to owners, reaching 399.8 million yuan ($56.9 million) for the six months ended June 30, 2024. The company's revenue for the same period grew by 13% year-over-year to 1.27 billion yuan ($181.2 million).</p>\n\n<p>Buoyed by its strong financial results, the pharmaceutical firm announced an interim dividend of HK$0.003 per share, further fueling investor enthusiasm and driving the stock's intraday rally.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Consun Pharmaceutical Soars 9% on Strong H1 Earnings, Dividend Boost</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Consun Pharmaceutical Soars 9% on Strong H1 Earnings, Dividend Boost\n</h2>\n\n<h4 class=\"meta\">\n\n2024-08-22 00:20 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Consun Pharmaceutical Group Limited (1681.HK) surged as much as 9.45% in intraday trading on Tuesday, August 21, 2024, as investors cheered the company's robust financial performance for the...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1189870175","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189870175","pubTimestamp":1724257222,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Consun Pharmaceutical Group Limited  surged as much as 9.45% in intraday trading on Tuesday, August 21, 2024, as investors cheered the company's robust financial performance for the first half of the year and its decision to increase its interim dividend.In a filing with the Hong Kong stock exchange, Consun Pharmaceutical reported a 15% increase in profit attributable to owners, reaching 399.8 million yuan  for the six months ended June 30, 2024. The company's revenue for the same peri","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业上半年盈利强劲，股息增加，股价飙升9%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Shares of Consun Pharmaceutical Group Limited (1681.HK) surged as much as 9.45% in intraday trading on Tuesday, August 21, 2024, as investors cheered the company's robust financial performance for the first half of the year and its decision to increase its interim dividend.\nIn a filing with the Hong Kong stock exchange, Consun Pharmaceutical reported a 15% increase in profit attributable to owners, reaching 399.8 million yuan ($56.9 million) for the six months ended June 30, 2024. The company's revenue for the same period grew by 13% year-over-year to 1.27 billion yuan ($181.2 million).\nBuoyed by its strong financial results, the pharmaceutical firm announced an interim dividend of HK$0.003 per share, further fueling investor enthusiasm and driving the stock's intraday rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189870175"}